stock
AEON Biopharma, Inc.
NYSE MKT | AEON
0.66
USD
+0.0605 (+10.07%)
AT CLOSE (AS OF Mar 14, 2025)
$668K
MARKET CAP
-
P/E Ratio
-0.13
EPS
$1.2K
52 Week High
$0.4
52 Week Low
REAL ESTATE & CONSTRUCTION
Sector
Profile
AEON Biopharma, Inc. Profile
Sector: REAL ESTATE & CONSTRUCTION
Industry: BLANK CHECKS
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. The company is headquartered in Newport Beach, California.
Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.